University of Minnesota. Driven to Discover.
Clinical trials will test a candidate vaccine for H7N9 flu in varying doses, some with immune boosters.
The patch produced a strong immune response and was well tolerated in 50 volunteers.
The proposed law would direct $200 million a year for 5 years to research.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2020 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.